.cancerresearch

The Big picture…

The Big Picture

Australian Cancer Research Foundation

.CANCERRESEARCH is a collaborative initiative facilitated by the Australian Cancer Research Foundation. Its focus is to bring together news, information, and leading opinion on cancer treatment, prevention, diagnosis and cure. We want you to be a part of the .CANCERRESEARCH community...

Please click here to learn more.

Home.

Cancer
Research

HOME.CANCERRESEARCH

Explore our home site for an idea of what .CANCERRESEARCH has to offer.

> Information on different types of cancer
> Cancer research endeavours of the past and near future
> Ways you can get involved

Visit our home site home.cancerresearch

Leukaemias

acrf
November 17, 2017

Brain cancers are the leading disease-related cause of death in Australian children. And survival rates have changed little in decades. As a paediatric oncologist, the worst conversation I can have with my patients or their parents is to tell them their tumour is incurable.

My hope is that we can replicate for brain cancer what has been achieved for leukaemia. The survival rate for the most common form of childhood leukaemia was once zero but today it’s 85%. To achieve this outcome for brain tumour patients, we will need to adopt a similar strategy as with leukaemia.

Read more…

 
acrf
March 8, 2017

A new method for finding hidden leukaemia cells by making them glow offers a more sensitive and accurate preclinical test for leukaemia drugs.

Read more…

 
acrf
March 2, 2017

Cancer researchers have identified for the first time how a new class of epigenetic drug engages with the immune system to kill off cancer cells.

Read more…

 
acrf
January 12, 2017

A new anti-cancer drug with the power to ‘melt away’ certain advanced forms of chronic lymphocytic leukaemia (CLL) has been granted approval in Australia.

Read more…

 
acrf
November 10, 2016

Researchers at Walter and Eliza Hall Institute in Melbourne have revealed that two internal ‘clocks’ control the immune cells enlisted to fight infection.

Read more…

 
acrf
October 25, 2016

A collaborative team of researchers has shown that a new compound blocks a protein that is essential for the sustained growth of up to a quarter of all cancers.

Read more…

 
acrf
October 18, 2016

The recently published study has overturned popular theory that acute lymphoblastic leukaemia (ALL) cells resist cancer treatment by hibernating in bone marrow.

Read more…

 
acrf
October 5, 2016

A newly approved adult leukaemia therapy called venetoclax could successfully target high-risk leukaemia subtypes in infants or children

Read more…

 
acrf
August 26, 2016

Venetoclax is a successful new therapy for patients with chronic lymphocytic leukaemia. It was developed based on a landmark discovery at Walter and Eliza Hall Institute in 1988.

Read more…

 
acrf
June 16, 2016

Researchers at Peter Mac have found a new lead that could fast-track the development of a more targeted and effective treatment for MLL Translocated Leukaemia.

Read more…

 
Subscribe to our newsletter